iRadimed Corporation (IRMD) Stock Analysis
Healthcare · Medical Devices
Wait for pullback to $86.94. At $88.99 the A.R:R is 0.9:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $86.94 (Ma200 Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Expensive valuation.
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI... Read more
Wait for pullback to $86.94. At $88.99 the A.R:R is 0.9:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $86.94 (Ma200 Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Expensive valuation. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Wide-moat business. Accumulate on weakness. Score 5.3/10, moderate confidence.
Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 71d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent Developments — iRadimed Corporation
Latest news
- Iradimed CEO Roger Susi sells $694k in common stock By Investing.com - Investing.com Australia — Investing.com Australia negative
- Iradimed CEO Roger Susi sells $694k in common stock - Investing.com — Investing.com negative
- IRadimed’s Earnings Call Highlights 3870-Led Growth - TipRanks — TipRanks positive
- Recent Price Trend in iRadimed (IRMD) is Your Friend, Here's Why - MSN — MSN positive
- Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors. - The Motley Fool — The Motley Fool negative
Generated 2026-05-20T20:21:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Wait for pullback to $86.94. At $88.99 the A.R:R is 0.9:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $86.94 (Ma200 Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Expensive valuation. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Wide-moat business. Accumulate on weakness. Target $100.30 (+12.7%), stop $80.82 (−10.1%), Setup A.R:R 2.1:1. Score 5.3/10, moderate confidence.
Take-profit target: $100.30 (+14.9% upside). Target $100.30 (+12.7%), stop $80.82 (−10.1%), Setup A.R:R 2.1:1. Stop-loss: $80.82.
Expensive valuation.
iRadimed Corporation trades at a P/E of 47.7 (forward 37.1). TrendMatrix value score: 2.8/10. Verdict: Buy (Wait for Entry).
9 analysts cover IRMD with a consensus score of 4.1/5. Average price target: $118.
What does iRadimed Corporation do?IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible...
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.